Tag: Dr. Michael Whitt

UTHSC Researchers Play Role in Supporting Development of COVID-19 Vaccines

Written by Peggy Reisser

|
Research

Researchers at the University of Tennessee Health Science Center have played a supporting role in the development of COVID-19 vaccines. To examine the efficacy of the Pfizer-BioNTech vaccine during development, the company needed a way to test the inhibitory effects of the antibodies generated after vaccination on virus infection. However, to work with SARS-CoV-2 requires… Read More

UTHSC Researchers Advance COVID-19 Antibody Knowledge with Paper in Prestigious Biomedical Research Journal

Written by Peggy Reisser

|
Research

  Researchers at the University of Tennessee Health Science Center working with colleagues at MD Anderson Cancer Center in Houston have found that some antibodies to SARS-CoV-2, the virus that causes COVID-19, are more protective than others, when it comes to reinfection. This information, discovered from the joint study and published online in the Journal… Read More